101 related articles for article (PubMed ID: 10873543)
1. Heterodimeric complex of RAR and RXR nuclear receptor ligand-binding domains: purification, crystallization, and preliminary X-ray diffraction analysis.
Bourguet W; Andry V; Iltis C; Klaholz B; Potier N; Van Dorsselaer A; Chambon P; Gronemeyer H; Moras D
Protein Expr Purif; 2000 Jul; 19(2):284-8. PubMed ID: 10873543
[TBL] [Abstract][Full Text] [Related]
2. Purification and crystallization of the heterodimeric complex of RARbeta and RXRalpha ligand-binding domains in the active conformation.
Pogenberg V; Guichou JF; Bourguet W
Acta Crystallogr D Biol Crystallogr; 2004 Jun; 60(Pt 6):1170-2. PubMed ID: 15159591
[TBL] [Abstract][Full Text] [Related]
3. Purification, functional characterization, and crystallization of the ligand binding domain of the retinoid X receptor.
Bourguet W; Ruff M; Bonnier D; Granger F; Boeglin M; Chambon P; Moras D; Gronemeyer H
Protein Expr Purif; 1995 Oct; 6(5):604-8. PubMed ID: 8535152
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains.
Bourguet W; Vivat V; Wurtz JM; Chambon P; Gronemeyer H; Moras D
Mol Cell; 2000 Feb; 5(2):289-98. PubMed ID: 10882070
[TBL] [Abstract][Full Text] [Related]
5. Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR.
Egea PF; Rochel N; Birck C; Vachette P; Timmins PA; Moras D
J Mol Biol; 2001 Mar; 307(2):557-76. PubMed ID: 11254382
[TBL] [Abstract][Full Text] [Related]
6. The isolation and characterization of purified heterocomplexes of recombinant retinoic acid receptor and retinoid X receptor ligand binding domains.
Tian K; Norris AW; Lin CL; Li E
Biochemistry; 1997 May; 36(19):5669-76. PubMed ID: 9153406
[TBL] [Abstract][Full Text] [Related]
7. Versatile copurification procedure for rapid isolation of homogeneous RAR-RXR heterodimers.
Iyer J; Bonnier D; Granger F; Iltis C; Andry V; Schultz P; Gronemeyer H
Protein Expr Purif; 1999 Jul; 16(2):308-14. PubMed ID: 10419826
[TBL] [Abstract][Full Text] [Related]
8. RARbeta ligand-binding domain bound to an SRC-1 co-activator peptide: purification, crystallization and preliminary X-ray diffraction analysis.
Kammerer S; Germain P; Flaig R; Peluso-Iltis C; Mitschler A; Rochel N; Gronemeyer H; Moras D
Acta Crystallogr D Biol Crystallogr; 2004 Nov; 60(Pt 11):2048-50. PubMed ID: 15502323
[TBL] [Abstract][Full Text] [Related]
9. Increased retinoic acid responsiveness in lung carcinoma cells that are nonresponsive despite the presence of endogenous retinoic acid receptor (RAR) beta by expression of exogenous retinoid receptors retinoid X receptor alpha, RAR alpha, and RAR gamma.
Wan H; Hong WK; Lotan R
Cancer Res; 2001 Jan; 61(2):556-64. PubMed ID: 11212249
[TBL] [Abstract][Full Text] [Related]
10. A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers.
Vivat V; Zechel C; Wurtz JM; Bourguet W; Kagechika H; Umemiya H; Shudo K; Moras D; Gronemeyer H; Chambon P
EMBO J; 1997 Sep; 16(18):5697-709. PubMed ID: 9312028
[TBL] [Abstract][Full Text] [Related]
11. Analysis of homo- and heterodimerization of retinoid receptors in solution.
Venepally P; Reddy LG; Sani BP
Arch Biochem Biophys; 1997 Jul; 343(2):234-42. PubMed ID: 9224735
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha.
Bourguet W; Ruff M; Chambon P; Gronemeyer H; Moras D
Nature; 1995 Jun; 375(6530):377-82. PubMed ID: 7760929
[TBL] [Abstract][Full Text] [Related]
13. Coexpression of nuclear receptor partners increases their solubility and biological activities.
Li C; Schwabe JW; Banayo E; Evans RM
Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2278-83. PubMed ID: 9122185
[TBL] [Abstract][Full Text] [Related]
14. Purification of the human RARgamma ligand-binding domain and crystallization of its complex with all-trans retinoic acid.
Rochel N; Renaud JP; Ruff M; Vivat V; Granger F; Bonnier D; Lerouge T; Chambon P; Gronemeyer H; Moras D
Biochem Biophys Res Commun; 1997 Jan; 230(2):293-6. PubMed ID: 9016769
[TBL] [Abstract][Full Text] [Related]
15. The "Phantom Effect" of the Rexinoid LG100754: structural and functional insights.
Sato Y; Ramalanjaona N; Huet T; Potier N; Osz J; Antony P; Peluso-Iltis C; Poussin-Courmontagne P; Ennifar E; Mély Y; Dejaegere A; Moras D; Rochel N
PLoS One; 2010 Nov; 5(11):e15119. PubMed ID: 21152046
[TBL] [Abstract][Full Text] [Related]
16. RAR antagonists diminish the level of DNA binding by the RAR/RXR heterodimer.
Poujol N; Margeat E; Baud S; Royer CA
Biochemistry; 2003 May; 42(17):4918-25. PubMed ID: 12718533
[TBL] [Abstract][Full Text] [Related]
17. Heterodimer formation by retinoid X receptor: regulation by ligands and by the receptor's self-association properties.
Dong D; Noy N
Biochemistry; 1998 Jul; 37(30):10691-700. PubMed ID: 9692959
[TBL] [Abstract][Full Text] [Related]
18. Purification and crystallization of the human RXRalpha ligand-binding domain-9-cisRA complex.
Egea PF; Moras D
Acta Crystallogr D Biol Crystallogr; 2001 Mar; 57(Pt 3):434-7. PubMed ID: 11223524
[TBL] [Abstract][Full Text] [Related]
19. Individual subunits of heterodimers comprised of retinoic acid and retinoid X receptors interact with their ligands independently.
Kersten S; Dawson MI; Lewis BA; Noy N
Biochemistry; 1996 Mar; 35(12):3816-24. PubMed ID: 8620004
[TBL] [Abstract][Full Text] [Related]
20. Auto-silencing by the retinoid X receptor.
Kersten S; Dong D; Lee Wy; Reczek PR; Noy N
J Mol Biol; 1998 Nov; 284(1):21-32. PubMed ID: 9811539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
